Arrowhead Pharmaceuticals (ARWR) Q4 2017 Earnings

12DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-0.2
-0.16
-0.11
-0.07

Details

Expected EPS
-0.09
Actual EPS
-0.15
Surprise EPS
-0.06
Surprise Percent
+66.67%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.15 per share for Q4 2017.

0 Comments

Share your thoughts